262 E. Patterson et al., “Association between dairy food consumption and risk of myocardial infarction in women differs by type of dairy food.”
263 G. Stix, “Got (skim) milk?: maybe a recipe for obesity and cancer.” Talking Back (blog),
264 X. Song et al., “Advanced glycation in D-galactose induced mouse aging model.”
265 X. Cui et al., “Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-α-lipoic acid”
266 X. Cui et al., “D-Galactose-caused life shortening in
267 K. Michaëlsson et al., “Milk intake and risk of mortality and fractures in women and men: cohort studies.”
268 J. M. Chan et al., “Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study.”
269 L.-Q. Qin et al., “Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review.”
270 M. Park et al., “Consumption of milk and calcium in midlife and the future risk of Parkinson disease.”
271 C. Rodriguez et al., “Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men.”
272 H. A. Bischoff-Ferrari et al., “Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies.”
273 J. J. B. Anderson et al., “Calcium intake from diet and supplements and the risk of coronary artery calcification and its progression among older adults: 10-year follow-up of the multi-ethnic study of atherosclerosis (MESA).”
274 K. Verburgh, “Nutrigerontology: why we need a new scientific discipline to develop diets and guidelines to reduce the risk of aging-related diseases.”
275 B. Vellas et al., “Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.”
276 M. Asif et al., “An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.”
277 P. V Vaitkevicius et al., “A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.”
278 D. A. Kass et al., “Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.”
279 W. C. Little et al., “The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.”
280 P. M. Keeney et al., “Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson’s disease cell model.”
281 S. Ellouze et al., “Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction.”
282 R. R. Thomas et al., “RhTFAM treatment stimulates mitochondrial oxidative metabolism and improves memory in aged mice.”